These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
127 related items for PubMed ID: 9851801
1. Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. Leitch IM, Boura AL, Botti C, Read MA, Walters WA, Smith R. J Clin Endocrinol Metab; 1998 Dec; 83(12):4510-3. PubMed ID: 9851801 [Abstract] [Full Text] [Related]
2. Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation. Clifton VL, Read MA, Leitch IM, Boura AL, Robinson PJ, Smith R. J Clin Endocrinol Metab; 1994 Aug; 79(2):666-9. PubMed ID: 8045990 [Abstract] [Full Text] [Related]
3. Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3',5'-monophosphate-mediated pathway. Clifton VL, Read MA, Leitch IM, Giles WB, Boura AL, Robinson PJ, Smith R. J Clin Endocrinol Metab; 1995 Oct; 80(10):2888-93. PubMed ID: 7559870 [Abstract] [Full Text] [Related]
4. Fetal placental vascular responses to corticotropin-releasing hormone in vitro. Effects of variation in oxygen tension. Donoghue JF, Leitch IM, Boura AL, Walters WA, Giles WB, Smith R, Read MA. Placenta; 2000 Sep; 21(7):711-7. PubMed ID: 10985975 [Abstract] [Full Text] [Related]
5. Nitric oxide regulation of corticotropin-releasing hormone release from the human perfused placenta in vitro. Roe CM, Leitch IM, Boura AL, Smith R. J Clin Endocrinol Metab; 1996 Feb; 81(2):763-9. PubMed ID: 8636301 [Abstract] [Full Text] [Related]
6. D-amino acid-substituted analogs of corticotropin-releasing hormone (CRH) and urocortin with selective agonist activity at CRH1 and CRH2beta receptors. Wei ET, Thomas HA, Christian HC, Buckingham JC, Kishimoto T. Peptides; 1998 Feb; 19(7):1183-90. PubMed ID: 9786168 [Abstract] [Full Text] [Related]
7. Adrenocorticotropin causes vasodilatation in the human fetal-placental circulation. Clifton VL, Read MA, Boura AL, Robinson PJ, Smith R. J Clin Endocrinol Metab; 1996 Apr; 81(4):1406-10. PubMed ID: 8636342 [Abstract] [Full Text] [Related]
8. Short-term effects of glucocorticoids in the human fetal-placental circulation in vitro. Clifton VL, Wallace EM, Smith R. J Clin Endocrinol Metab; 2002 Jun; 87(6):2838-42. PubMed ID: 12050259 [Abstract] [Full Text] [Related]
9. Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. Petraglia F, Florio P, Benedetto C, Marozio L, Di Blasio AM, Ticconi C, Piccione E, Luisi S, Genazzani AR, Vale W. J Clin Endocrinol Metab; 1999 Apr; 84(4):1420-3. PubMed ID: 10199789 [Abstract] [Full Text] [Related]
10. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands. Krause K, Schnitger A, Fimmel S, Glass E, Zouboulis CC. Horm Metab Res; 2007 Feb; 39(2):166-70. PubMed ID: 17326013 [Abstract] [Full Text] [Related]
11. U46619-mediated vasoconstriction of the fetal placental vasculature in vitro in normal and hypertensive pregnancies. Read MA, Leitch IM, Giles WB, Bisits AM, Boura AL, Walters WA. J Hypertens; 1999 Mar; 17(3):389-96. PubMed ID: 10100077 [Abstract] [Full Text] [Related]
12. CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. Wiley KE, Davenport AP. Br J Pharmacol; 2004 Oct; 143(4):508-14. PubMed ID: 15381637 [Abstract] [Full Text] [Related]
13. Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-proteins. Grammatopoulos DK, Randeva HS, Levine MA, Katsanou ES, Hillhouse EW. Mol Endocrinol; 2000 Dec; 14(12):2076-91. PubMed ID: 11117536 [Abstract] [Full Text] [Related]
14. Effect of inhibition of nitric oxide synthase and guanylate cyclase on hydralazine-induced vasodilatation of the human fetal placental circulation. Leitch IM, Read MA, Boura AL, Walters WA. Clin Exp Pharmacol Physiol; 1994 Aug; 21(8):615-22. PubMed ID: 7529152 [Abstract] [Full Text] [Related]
15. Corticotropin-releasing hormone and urocortin induce secretion of matrix metalloproteinase-9 (MMP-9) without change in tissue inhibitors of MMP-1 by cultured cells from human placenta and fetal membranes. Li W, Challis JR. J Clin Endocrinol Metab; 2005 Dec; 90(12):6569-74. PubMed ID: 16174714 [Abstract] [Full Text] [Related]
16. Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides. Karteris E, Vatish M, Hillhouse EW, Grammatopoulos DK. J Clin Endocrinol Metab; 2005 Jun; 90(6):3680-7. PubMed ID: 15784708 [Abstract] [Full Text] [Related]
17. Localization and characterization of urocortin during human pregnancy. Clifton VL, Gu Q, Murphy VE, Schwartz J, Madsen G, Smith R. Placenta; 2000 Nov; 21(8):782-8. PubMed ID: 11095927 [Abstract] [Full Text] [Related]
18. Vasodilatory response of fetoplacental vasculature to adrenomedullin after constriction with the thromboxane sympathomimetic U46619. Hoeldtke NJ, Wagner RK, Calhoun BC, Hume RF. Am J Obstet Gynecol; 2000 Dec; 183(6):1573-8. PubMed ID: 11120530 [Abstract] [Full Text] [Related]
19. Urocortin-induced relaxation in the human internal mammary artery. Chen ZW, Huang Y, Yang Q, Li X, Wei W, He GW. Cardiovasc Res; 2005 Mar 01; 65(4):913-20. PubMed ID: 15721872 [Abstract] [Full Text] [Related]
20. Characterising the corticotropin-releasing hormone (CRH) receptors mediating CRH and urocortin actions during human pregnancy and labour. Hillhouse EW, Grammatopoulos DK. Stress; 2001 Dec 01; 4(4):235-46. PubMed ID: 22432144 [Abstract] [Full Text] [Related] Page: [Next] [New Search]